Outlook Therapeutics, Inc. (OTLK) Tops Q1 EPS by 1c

Outlook Therapeutics, Inc. (NASDAQ: OTLK) reported Q1 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05).

For earnings history and earnings-related data on Outlook Therapeutics, Inc. (OTLK) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Alphabet slides over 6% as AI brain drain and SpaceX slump converge
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits